Methods for storage and retrieval of functional mature retinal cells

Abstract

A method for the isolation, storage and retrieval of mature retinal cells is disclosed. The Method is applicable to adult mammalian cone cells, and more particularly human cone cells, and to healthy as well as pathological or otherwise altered cone cells. A kit for the isolation, storage and retrieval of mature retinal cells is also described.

1 - 16 . (canceled) 
     
     
         17 . A method for treating retinal dysfunction in a subject, comprising:
 introducing into an eye of said subject an effective amount of retinal cone cells stored and retrieved using a method comprising the steps of:   incubating freshly isolated retinal tissue with a retinal tissue digestion solution comprising a protease and CaCl 2 ;   removing said retinal tissue digestion solution to yield an enzyme-treated retinal tissue;   triturating said enzyme-treated retinal tissue in a retinal cell suspension medium to form a retinal cell suspension comprising retinal cone cells;   adding fetal bovine serum (FBS) and dimethyl sulfoxide (DMSO) to said retinal cell suspension;   freezing and storing said retinal cell suspension comprising FBS and DMSO in liquid nitrogen;   thawing said retinal cell suspension;   washing and culturing said thawed retinal cells with a retinal cell culture medium comprising Choline Cl; and   isolating mature retinal cone cells recovered from said frozen retinal cell suspension.   
     
     
         18 . The method of  claim 17 , wherein said retinal dysfunction is selected from the group consisting of photoreceptor degeneration, retinal detachment, retinal trauma, photic lesions caused by laser or sunlight; a macular hole, macular edema; night blindness and color blindness, ischemic retinopathy, and inflammatory conditions. 
     
     
         19 . The method of  claim 17 , wherein said retinal cells are introduced into said eye with a substance that stimulate differentiation of neuroretina-derived stem cells into photoreceptor cells. 
     
     
         20 . (canceled) 
     
     
         21 . The method of  claim 17 , wherein said isolated mature retinal cone cells are capable of maintaining I Dep  and I h  levels that are not statistically different from I Dep  and I h  levels of freshly isolated retinal cone cells not subjected to freezing and thawing as measured by patch clamp analysis after being frozen for at least 6 months at −170° C. 
     
     
         22 . The method of  claim 17 , wherein said protease is selected from the group consisting of trypsin, chymotrypsin, pepsin, papain, elastase A and mixtures thereof. 
     
     
         23 . The method of  claim 22 , wherein said protease is papain. 
     
     
         24 . The method of  claim 17 , wherein said tissue digestion solution further contains a collagenase. 
     
     
         25 . The method of  claim 17 , wherein said tissue digestion solution further contains an enzyme activator. 
     
     
         26 . The method of  claim 25 , wherein said enzyme activator is cysteine. 
     
     
         27 . The method of  claim 17 , wherein said tissue digestion solution comprises NaCl, NaHCO 3 , sodium pyruvate, KCl and NaH 2 PO 4 . 
     
     
         28 . The method of  claim 17 , wherein said tissue digestion solution comprises 114 mM NaCl, 25 mM NaHCO 3 , 1 mM soduim pyruvate, 3 mM KCl, 0.5 mM NaH 2 PO 4 , 0.5 mM CaCl 2 , and 0.02 mM Phenol red. 
     
     
         29 . The method of  claim 17 , wherein said tissue digestion solution has a pH of 7.2-7.3. 
     
     
         30 . The method of  claim 17 , wherein said freshly isolated retinal tissue is incubated with a retinal tissue digestion solution containing a protease at a temperature between about 18° C. and 42° C. for about 15-90 min. 
     
     
         31 . The method of  claim 17 , wherein said freshly isolated retinal tissue is incubated with a retinal tissue digestion solution containing a protease at room temperature for about 30-40 min. 
     
     
         32 . The method of  claim 17 , wherein said retinal cell culture medium comprises a growth factor selected from the group consisting of human epidermal growth factor, human fibroblast growth factor-2 and platelet-derived growth factor. 
     
     
         33 . The method of  claim 17 , wherein said mature retinal cone cells have an I Clca  level that is statistically lower than the I Clca  level of freshly isolated retinal cone cells as measured by patch clamp analysis, after being frozen for at least 6 months at −170° C. 
     
     
         34 . The method of  claim 17 , wherein the retinal cell culture medium comprises preconditioned culture medium prepared by culturing Muller glial cells in a culture medium suitable for cone survival. 
     
     
         35 . The method of  claim 34 , wherein the retinal cell culture medium further comprises insulin, h-transferrin, putrascine, selenite and glutamine. 
     
     
         36 . The method of  claim 17 , wherein said retinal cell culture medium comprises platelet-derived growth factor. 
     
     
         37 . The method of  claim 17 , further comprising the step of dissecting freshly isolated retinal tissue into small fragments in cold CO 2 -independent medium, prior to incubation with the retinal tissue digest solution comprising the protease and CaCl 2 .